Topics

Pharmaceutical Industry

Proposed olive oil testing would look for unpure or mislabeled products

Proposed olive oil testing would look for unpure or mislabeled products

Amid growing questions about the alleged mislabeling of olive oil, a congressional committee is asking the U.S. Food and Drug Administration to test imports to look for unpure or misbranded products.

But members of the industry in Baltimore and elsewhere disagree about how to best weed out fraud and reassure consumers.

Under a federal budget proposal for fiscal 2017, the FDA would be required to sample olive oil imports and present findings within nine months to Congress, along with a plan "to ensure consumer safety and proper labeling of imported olive oil," according to a House appropriations bill report.

"The Committee [on Appropriations] is concerned...

73°